PubMed Health⌕ Search

PubMed · 11460995

Transposition complexes with systemic obstruction.

Abstract

The arterial switch operation is currently the procedure of choice for transposition of the great arteries and double-outlet right ventricle with subpulmonary ventricular septal defect. While the results of surgical repair have improved tremendously in recent years, the presence of associated lesions continues to make this a surgically challenging malformation. The association of these so-called transposition complexes with systemic obstruction has recently received increased attention. Systemic obstruction may occur at the subaortic level, in the aortic arch, or at both levels. Valvar aortic stenosis or atresia is extremely rare. Resection of hypertrophied muscle bundles with or without pericardial patch augmentation is frequently enough to deal with obstruction at the subaortic level, which becomes the subpulmonary area following arterial switch operation. Aortic arch obstruction associated with intracardiac defects has traditionally been addressed with a staged approach, dealing first with the arch obstruction followed later by intracardiac repair. The results with this approach have been disappointing. At the Montréal Children's Hospital, we have obtained superior results using a single-stage approach. Therefore, we have advocated the use of pulmonary homograft patch aortoplasty for aortic arch reconstruction at the time of intracardiac repair to completely remove any anatomic afterload. Since 1989, in 22 consecutive patients undergoing single-stage anatomic repair of transposition complexes associated with aortic arch obstruction, we have had no early deaths, one late death of a noncardiac cause, and one recoarctation requiring balloon dilatation. In the last 2 years, we have been able to perform all our aortic arch reconstructions avoiding the use of circulatory arrest.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

C I Tchervenkov, S J Korkola. 2001. Transposition complexes with systemic obstruction.. https://pubmed.ncbi.nlm.nih.gov/11460995/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Right ventricle to pulmonary artery conduit improves outcome after stage I Norwood for hypoplastic left heart syndrome.

BACKGROUND: Diastolic run off into the pulmonary circulation and labile coronary perfusion are thought to contribute to morbidity and mortality after the Norwood procedure (NP). We compared outcomes from the use of a RV to PA conduit (RV/PA) or a modified Blalock-Taussig shunt (BTS), physiologically distinct sources of pulmonary blood flow. METHODS AND RESULTS: Review of 56 consecutive patients who underwent a Norwood procedure with a RV/PA (n=36) or a BTS (n=20) between 2000 and 2002. Median age was 4.5 days (range 1 to 40) and median weight was 3.1 kg (range 1.8 to 4.1). The RV/PA was constructed with a 5-mm conduit. Patients in the BTS group received a 4-mm shunt. Comparisons between RV/PA and BTS groups showed no difference for weight, gestational age, prenatal diagnosis, HLHS variant, associated diagnoses, ascending aortic size, ventricular function, AV valve function, and pulmonary venous obstruction. Operative survival was higher with RV/PA [33/36 (92%) versus 14/20 (70%); P=0.05]. Patients with RV/PA had less need for ventilatory manipulations to balance the Qp/Qs (1/36 v/s 8/20; P=0.001), delayed sternal closure (6/36 v/s 7/20; P=0.001), and extracorporeal support (5/36 v/s 7/20; P=0.036). RV/PA patients had more favorable postoperative hemodynamics: higher diastolic blood pressure without changes in systolic blood pressure at 1, 8, 24, 48 hours after the NP (46.3 v/s 39.5; 47.2 v/s 42.1; 46.1 v/s 37.1; and 47.1 v/s 40.2; all P=0.001). CONCLUSIONS: RV/PA simplifies postoperative management and improves hospital survival after NP for HLHS.

Anastomosis, Surgical↗

Intraperitoneal administration of the angiogenesis inhibitor thalidomide does not impair anastomotic healing following large bowel resection in a rabbit model.

The effects of thalidomide after intraperitoneal instillation on the healing of colonic anastomoses are not known. A series of 40 New Zealand White rabbits underwent an end-to-end colonic anastomosis. The animals were randomized into four groups. Groups 1 (n = 10) and 2 (n = 10) were treated with dissolved thalidomide 200 mg/kg intraperitoneally, whereas groups 3 (n = 10) and 4 (n = 10) were treated only with the dissolver. Animals were sacrificed at day 3 (groups 1, 3) and day 7 (groups 2, 4). Anastomotic healing was tested by measuring the bursting pressure in vitro. Immunohistochemical staining of the anastomotic site was performed with polyclonal antibodies against CD31 and Mib-1, to determine a possible antiangiogenic or antiproliferative effect. Statistical analysis was performed using Spearman's log rank correlation and paired t-test. On postoperative day 3 (p > 0.19) and postoperative day 7 (p > 0.73), there was no difference in bursting pressure in the treatment and the control groups. Angiogenesis scores were reduced at day 3 in the thalidomide group (p < 0.05), but did not differ between the groups at day 7. White blood cell counts were decreased in the treatment groups at day 3 (p < 0.01) and day 7, compared to control groups (p < 0.01). There was no difference in the expression of Mib-1 in either group at day 3 or day 7. The intraperitoneal administration of thalidomide does not interfere with the healing of colonic anastomosis. Although the angiogenesis score is diminished at day 3, this did not lead to a reduced bursting pressure at day 3 or day 7.

Anastomosis, Surgical↗